Milano's largest district entirely dedicated to innovation

Born on the premises of Milano World Expo 2015 dedicated to the theme “Feeding the Planet, Energies for Life”, MIND Milano Innovation District, combines its scientific and clinical inclination in the life sciences sector with a unique international platform to capitalize the global and local research and business excellences.

Thanks to a public-private investment of > 4 billion euros, once fully operational, MIND will host over 60,000 people/day, including 18,000 students and 5,000 researchers, making it one of the top 200 Italian municipalities in terms of population.

MIND is a structured system of interaction aimed at TT and open innovation between universities, research bodies and companies, is organised in different thematic areas with access to research infrastructure, know-how, funds and networks. Despite the pandemic outbreak, such an integrated approach has been allowing the major urban developments to proceed fast, and to put in place a series of research and innovation projects even before physical spaces became available.

The avant-garde laboratories, designed by champions in the field of industrial and public-setting design, intend to provide shared spaces for cross-companies teams as well as independent spaces. Innovative demonstrators are at the disposal of the health supply chain to test the potential of new techs for processes, products and services transformations.

Leading Life Sciences companies such as AstraZeneca and Illumina, along with startups have already chosen the district for the establishment of their new headquarters.


The companies involved in MIND are already working, together with the Anchors and national and international partners, on a series of pilot projects using the district as a test-bed to experiment new systems of personalized medicine, mobility, logistics, energy and data sharing. Such synergies evolve around three priority strands:

  • big data and AI, smart materials and devices
  • genomics
  • advanced and addictive manufacturing


TT, open innovation

Entry barriers in the Pharma, Biotech and Medical Devices market remains high due to techs, laboratories and equipment costs, but also because of regulatory barriers and the difficulty for smaller organisations to interact with both universities and large companies. By bringing together four anchors such as Human Technopole, Research Hospital Galeazzi, the University of Milano, Fondazione Triulza and private companies, MIND aims at becoming an internationally renewed flagship initiative in breeding ground for health prevention, improved diagnostics and advanced healthcare, always keeping in mind a citizen-centered paradigm.


Located inside MIND, Human Technopole (HT) is a large-scale, government-funded, research infrastructure that contributes to improving human health and well-being by developing new approaches to personalized and preventive medicine.

To date, over 150 international scientists work in the facility, while this number is expected to quintuple by 2024.

Alongside laboratories and highly qualified researchers, HT is already enlisted in the world’s most advanced hubs thanks to the acquisition of exclusive computing, storage and imaging equipment. Genomics studies, big data analysis and new diagnostics techniques are supported by unique supercomputers able to store hundreds of petabytes located in one of the main facilities. Please read the dedicated article for more information.

Federated Innovation @MIND

Federated Innovation @MIND is a public-private collaborative model Promoted by Lendlease and catalyzed by Cariplo Factory, Federated Innovation is the result of a process that originated with MINDlab, a call collecting expressions of interest from companies developing innovative technologies in 11 thematic areas: Agrifood Tech & Wellbeing; Life Sciences & Healthcare; Retail Tech; Fintech; Proptech & Smart Spaces; Security & Defense; Construction Tech; Urban Digital Tech; Greentech & Circular Economy; Mobility & Logistics; Energy.

Born in February 2021, Federated Innovation @MIND's mission is to aggregate public entities and private companies in a virtuous environment intend to work together to accelerate the translation of ideas into new products, processes and services in the Future of Health and City of the Future.

Through a multidisciplinary and intersectoral approach, the initiatives intends to go beyond open innovation and the traditional business innovation, encouraging cooperation between the different players of the market through a Collaborate to Compete model which surpasses standard open innovation, with a legal structure to protect intellectual property.

The companies operate with their own innovation teams within Federated Innovation, and each project is called to answer to the priorities and strategic challenges articulated by companies in the district's Innovation Agenda.